A Phase 1 Single Center, Open-Label, Randomized Two-Period, Two-Arm Crossover Study of the Relative Bioavailability of a Single Dose of CTP-543 in Fasted and Fed Conditions in Healthy Volunteers
Latest Information Update: 17 Jun 2019
At a glance
- Drugs Deuruxolitinib (Primary)
- Indications Alopecia areata
- Focus Pharmacokinetics
- Sponsors Concert Pharmaceuticals
- 12 Jun 2019 Status changed from active, no longer recruiting to completed.
- 28 Mar 2019 Status changed from not yet recruiting to active, no longer recruiting.
- 15 Mar 2019 Planned End Date changed to 1 May 2019.